An interventional study of Standard Care for people after hip fracture and Standard Care + exercise intervention in Hip Fracture, sponsored by University of British Columbia. Withdrawn. Open to female participants aged 65 Years to 105 Years. Per ClinicalTrials.gov, last updated 2023-04-28.
Sponsored by University of British Columbia · Not applicable, Interventional, and Treatment
Patients who have suffered a first hip fracture have a higher risk of falling and sustaining another hip fracture compared with age-matched adults who did not fracture. Although exercise is key to reversing this pattern, there have been very few trials that aimed to improve muscle strength and balance as well as enhance bone health following hip fracture. Therefore, we propose to conduct an RCT that delivers either 12 months of standard care or standard care plus graduated exercise program for older women who have sustained a recent hip fracture.
2,261 studies on the registry are indexed under Fractures, Bone; 325 are open to participants now.
Browse Fractures, Bone studies →University of British Columbia is the lead sponsor of 1,309 studies on the registry; 253 are open to participants now.
Of its 6 completed or terminated interventional studies of FDA-regulated products, 1 (17%) have results posted.
Counted across the registry records on this site, refreshed daily.
Inclusion Criteria:
Standard Care for people after a hip fracture
Other: Standard Care for people after hip fracture
Standard Care + exercise intervention
Other: Standard Care + exercise intervention
Fall rate, measured by self-reported daily fall diaries, will be collected monthly at the exercise classes and followed up by an independent investigator
Time frame: Monthly
No study locations are listed for this record.
This study is withdrawn, as verified in Apr 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of British Columbia